The United Laboratories International Holdings Limited (3933.HK)

HKD 12.68

(-0.94%)

EBITDA Summary of The United Laboratories International Holdings Limited

  • The United Laboratories International Holdings Limited's latest annual EBITDA in 2023 was 3.97 Billion CNY , up 56.22% from previous year.
  • The United Laboratories International Holdings Limited's latest quarterly EBITDA in 2024 Q2 was 2.01 Billion CNY , down 0.0% from previous quarter.
  • The United Laboratories International Holdings Limited reported an annual EBITDA of 2.53 Billion CNY in 2022, up 28.36% from previous year.
  • The United Laboratories International Holdings Limited reported an annual EBITDA of 1.97 Billion CNY in 2021, up 8.25% from previous year.
  • The United Laboratories International Holdings Limited reported a quarterly EBITDA of 1.79 Billion CNY for 2023 Q2, down 0.0% from previous quarter.
  • The United Laboratories International Holdings Limited reported a quarterly EBITDA of 1.9 Billion CNY for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of The United Laboratories International Holdings Limited (2023 - 2006)

Historical Annual EBITDA of The United Laboratories International Holdings Limited (2023 - 2006)

Year EBITDA EBITDA Growth
2023 3.97 Billion CNY 56.22%
2022 2.53 Billion CNY 28.36%
2021 1.97 Billion CNY 8.25%
2020 1.82 Billion CNY 13.49%
2019 1.6 Billion CNY -1.52%
2018 1.63 Billion CNY 20.55%
2017 1.35 Billion CNY 29.99%
2016 1.04 Billion CNY -19.73%
2015 1.17 Billion CNY -3.15%
2014 1.39 Billion CNY 56.51%
2013 857.37 Million CNY 12.46%
2012 762.41 Million CNY 18.04%
2011 641.37 Million CNY -54.73%
2010 1.42 Billion CNY 44.64%
2009 986.43 Million CNY 24.08%
2008 794.98 Million CNY 2.87%
2007 772.77 Million CNY 55.58%
2006 496.71 Million CNY 0.0%

Peer EBITDA Comparison of The United Laboratories International Holdings Limited

Name EBITDA EBITDA Difference
Pak Fah Yeow International Limited 150.4 Million HKD -2544.077%
Grand Pharmaceutical Group Limited 2.96 Billion HKD -34.051%
Extrawell Pharmaceutical Holdings Limited -129.51 Million HKD 3170.33%
Wai Yuen Tong Medicine Holdings Limited 113.79 Million HKD -3394.518%
Qianhai Health Holdings Limited -50.22 Million HKD 8017.124%
Lee's Pharmaceutical Holdings Limited 109.82 Million HKD -3521.1%
Essex Bio-Technology Limited 418.37 Million HKD -850.504%
Tongfang Kontafarma Holdings Limited 76.63 Million HKD -5089.268%
PuraPharm Corporation Limited -26.16 Million HKD 15296.194%
SSY Group Limited 2.11 Billion HKD -88.063%
JBM (Healthcare) Limited 204.39 Million HKD -1845.639%
Jacobson Pharma Corporation Limited 429.92 Million HKD -824.982%
China Resources Pharmaceutical Group Limited 15.43 Billion HKD 74.229%